Correction to: IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas
Am J Clin Pathol
.
2024 Jan 4;161(1):107.
doi: 10.1093/ajcp/aqad173.
PMID:
37991998
PMCID:
PMC10765148
DOI:
10.1093/ajcp/aqad173
No abstract available
Publication types
Published Erratum
Grants and funding
T32 GM136651/GM/NIGMS NIH HHS/United States
1T32GM136651-01/NH/NIH HHS/United States